A number of studies have shown that KDM4B is often overexpressed in breast, colorectal, ovarian, lung, gastric and prostate cancer cells, resulting in H3K9me3 demethylation, subsequent gene expression changes and genomic instability to induce tumors [32,33,34,35,36]. Here, KDM4B is linked to prostate carcinoma.